These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21115916)

  • 61. Protein kinase CK2 inhibition induces cell death via early impact on mitochondrial function.
    Qaiser F; Trembley JH; Kren BT; Wu JJ; Naveed AK; Ahmed K
    J Cell Biochem; 2014 Dec; 115(12):2103-15. PubMed ID: 25043911
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Curcumin Veto the Effects of Osteopontin (OPN) Specific Inhibitor on Leukemic Stem Cell Colony Forming Potential via Promotion of OPN Overexpression.
    Mohammadi S; Ghaffari SH; Shaiegan M; Nikogoftar Zarif M; Nikbakht M; Alimoghaddam K; Ghavamzadeh A
    Int J Hematol Oncol Stem Cell Res; 2016 Jul; 10(3):120-9. PubMed ID: 27489587
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Chidamide and apatinib are therapeutically synergistic in acute myeloid leukemia stem and progenitor cells.
    Zhao H; Jiang Y; Lin F; Zhong M; Tan J; Zhou Y; Liu L; Li G; Deng M; Xu B
    Exp Hematol Oncol; 2022 May; 11(1):29. PubMed ID: 35581670
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A small molecule screening strategy with validation on human leukemia stem cells uncovers the therapeutic efficacy of kinetin riboside.
    McDermott SP; Eppert K; Notta F; Isaac M; Datti A; Al-Awar R; Wrana J; Minden MD; Dick JE
    Blood; 2012 Feb; 119(5):1200-7. PubMed ID: 22160482
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The effect of apigenin and chemotherapy combination treatments on apoptosis-related genes and proteins in acute leukaemia cell lines.
    Mahbub AA; Le Maitre CL; Cross NA; Jordan-Mahy N
    Sci Rep; 2022 May; 12(1):8858. PubMed ID: 35614109
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Acute myeloid leukemia stem cells].
    Goyama S
    Rinsho Ketsueki; 2020; 61(4):336-342. PubMed ID: 32378578
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Mitochondria: A Galaxy in the Hematopoietic and Leukemic Stem Cell Universe.
    Panuzzo C; Jovanovski A; Pergolizzi B; Pironi L; Stanga S; Fava C; Cilloni D
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486249
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Bcl-2 inhibition combined with PPARα activation synergistically targets leukemic stem cell-like cells in acute myeloid leukemia.
    Xie C; Zhou H; Qin D; Zheng H; Tang Y; Li W; Zhou J; Liu L; Yu X; Duan H; Zhou Y; Li Z; Fang Z; Luo Y; Carter BZ; Xu B; Zha J
    Cell Death Dis; 2023 Aug; 14(8):573. PubMed ID: 37644011
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Aurora A kinase expression is increased in leukemia stem cells, and a selective Aurora A kinase inhibitor enhances Ara-C-induced apoptosis in acute myeloid leukemia stem cells.
    Kim SJ; Jang JE; Cheong JW; Eom JI; Jeung HK; Kim Y; Hwang DY; Min YH
    Korean J Hematol; 2012 Sep; 47(3):178-85. PubMed ID: 23071472
    [TBL] [Abstract][Full Text] [Related]  

  • 70. ALDH marks leukemia stem cell.
    Fleischman AG
    Blood; 2012 Apr; 119(15):3376-7. PubMed ID: 22500050
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hematein, a casein kinase II inhibitor, inhibits lung cancer tumor growth in a murine xenograft model.
    Hung MS; Xu Z; Chen Y; Smith E; Mao JH; Hsieh D; Lin YC; Yang CT; Jablons DM; You L
    Int J Oncol; 2013 Nov; 43(5):1517-22. PubMed ID: 24008396
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Primary Mechanisms of CD34
    Wang DP; Shi W; Ge WW; Zhang JX; Zhao LP; Chen X; Dong L; Sun YQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Dec; 27(6):1761-1766. PubMed ID: 31839035
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Differential redox-regulation and mitochondrial dynamics in normal and leukemic hematopoietic stem cells: A potential window for leukemia therapy.
    Mattes K; Vellenga E; Schepers H
    Crit Rev Oncol Hematol; 2019 Dec; 144():102814. PubMed ID: 31593878
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hematopoietic stem and progenitor cell membrane-coated vesicles for bone marrow-targeted leukaemia drug delivery.
    Li J; Wu H; Yu Z; Wang Q; Zeng X; Qian W; Lu S; Jiang L; Li J; Zhu M; Han Y; Gao J; Qian P
    Nat Commun; 2024 Jul; 15(1):5689. PubMed ID: 38971796
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Mitochondrial metabolism as a potential therapeutic target in myeloid leukaemia.
    de Beauchamp L; Himonas E; Helgason GV
    Leukemia; 2022 Jan; 36(1):1-12. PubMed ID: 34561557
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The concept of leukaemic stem cells in acute myeloid leukaemia 25 years on: hitting a moving target.
    Hokland P; Woll PS; Hansen MC; Bill M
    Br J Haematol; 2019 Oct; 187(2):144-156. PubMed ID: 31372979
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Could Vitamin D Analogues Be Used to Target Leukemia Stem Cells?
    García-Ramírez I; Martín-Lorenzo A; González-Herrero I; Rodriguez-Hernández G; Vicente-Dueñas C; Sánchez-García I
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27275819
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Population dynamics of normal and leukaemia stem cells in the haematopoietic stem cell niche show distinct regimes where leukaemia will be controlled.
    MacLean AL; Lo Celso C; Stumpf MP
    J R Soc Interface; 2013 Apr; 10(81):20120968. PubMed ID: 23349436
    [TBL] [Abstract][Full Text] [Related]  

  • 79. ORP4L Extracts and Presents PIP
    Zhong W; Xu M; Li C; Zhu B; Cao X; Li D; Chen H; Hu C; Li R; Luo C; Pan G; Zhang W; Lai C; Wang T; Du X; Chen H; Xu G; Olkkonen VM; Lei P; Xu J; Yan D
    Cell Rep; 2019 Feb; 26(8):2166-2177.e9. PubMed ID: 30784597
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Immunophenotypic features of early haematopoietic and leukaemia stem cells.
    Reuvekamp T; Bachas C; Cloos J
    Int J Lab Hematol; 2024 Jul; ():. PubMed ID: 39045906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.